Last 10,700 KRW
Change Today -100.00 / -0.93%
Volume 18.0K
000230 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:21 AM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

il dong pharmaceutical co (000230) Snapshot

Open
10,900
Previous Close
10,800
Day High
10,900
Day Low
10,550
52 Week High
12/13/12 - 14,700
52 Week Low
06/29/12 - 6,300
Market Cap
268.2B
Average Volume 10 Days
32.2K
EPS TTM
697.00
Shares Outstanding
25.1M
EX-Date
12/27/12
P/E TM
15.4x
Dividend
150.00
Dividend Yield
1.40%
Current Stock Chart for IL DONG PHARMACEUTICAL CO (000230)

Related News

No related news articles were found.

il dong pharmaceutical co (000230) Related Businessweek News

No Related Businessweek News Found

il dong pharmaceutical co (000230) Details

ILDong Pharmaceutical Co., Ltd. produces pharmaceutical specialties, pharmaceutical raw materials, and environmental products. It offers pharmaceuticals, such as drugs acting on circulatory, digestive, respiratory, and endocrine systems; probiotics; psychotropic drugs; antiinfectives; anticancer drugs; topical preparations; and vitamins, minerals, and nutrients. The company produces raw materials that include synthetics and probiotics. ILDong Pharmaceutical Co. is headquartered in Seoul, South Korea.

1,348 Employees
Last Reported Date: 05/30/13

il dong pharmaceutical co (000230) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

il dong pharmaceutical co (000230) Key Developments

ILDong Pharmaceutical Co. Ltd. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013

ILDong Pharmaceutical Co. Ltd. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013 . Venue: Shangri-La Hotel, 29 Zizhuyuan Road, Beijing 100089, China.

ILDong Pharmaceutical Co. Ltd., Annual General Meeting, Mar 15, 2013

ILDong Pharmaceutical Co. Ltd., Annual General Meeting, Mar 15, 2013., at 10:00 Korea Standard Time. Location: Ildong Road 227. Agenda: To consider audit sales reporting; to approve election of directors; to consider audit appointment; to consider the approval of consolidated financial statements; to approve directors remuneration limit; to approve the audit fees limit; and to consider the other references useful for making investment decisions.

ILDong Pharmaceutical Co. Ltd. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013

ILDong Pharmaceutical Co. Ltd. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000230:KS 10,700.00 KRW -100.00

000230 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000230.
View Industry Companies
 

Industry Analysis

000230

Industry Average

Valuation 000230 Industry Range
Price/Earnings 10.7x
Price/Sales 0.7x
Price/Book 0.8x
Price/Cash Flow 11.0x
TEV/Sales 0.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IL DONG PHARMACEUTICAL CO, please visit www.ildong.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.